Announcement on Acquisition of a Drug Technology (Patent Right) for the Treatment of Chronic Heart Failure by a Wholly-owned Subsidiary and Signing of the Technology (Patent Right) Transfer Agreement

About this update from Guangxi Wuzhou Zhongheng Group Co., Ltd. Class A

Announcement on Acquisition of a Drug Technology (Patent Right) for the Treatment of Chronic Heart Failure by a Wholly-owned Subsidiary and Signing of the Technology (Patent Right) Transfer AgreementThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Guangxi Wuzhou Zhongheng Group Co., Ltd. Class A